1.  51
    Exploring the Role Performance of Corporate Ethics Officers.Henry Adobor - 2006 - Journal of Business Ethics 69 (1):57-75.
    Organizations continue to show renewed focus on managing their ethics programs by developing organizational infrastructures to support their ethics implementation efforts. An important part of this process has been the creation of an ethics officer position. Whether individuals appointed to the position are successful in the role or not may depend on a number of factors. This study presents a suggested framework for their effectiveness. The framework includes a focus on personal, organizational and situational factors to predict performance in the (...)
    Direct download (4 more)  
    Export citation  
    Bookmark   11 citations  
  2.  17
    Vulnerability, Moral responsibility, and Moral Obligations: the case of Industrial Action in the Medical and Allied Professions.Henry Adobor - 2022 - Medicine, Health Care and Philosophy 25 (3):333-349.
    The article addresses issues at the nexus of physician industrial action, moral agency, and responsibility. There are situations in which we find ourselves best placed to offer aid to those who may be in vulnerable positions, a behavior that is consistent with our everyday moral intuitions. In both our interpersonal relationships and social life, we make frequent judgments about whether to praise or blame someone for their actions when we determine that they should have acted to help a vulnerable person. (...)
    Direct download (2 more)  
    Export citation  
  3.  99
    Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry. [REVIEW]Henry Adobor - 2012 - Journal of Business Ethics 105 (2):239-255.
    The outsourcing of medical research has become a strategic imperative in the global pharmaceutical industry. Spurred by the challenges of competition, the need for speed in drug development, and increasing domestic costs, pharmaceutical companies across the globe continue to outsource critical parts of their value chain activities, namely contract clinical research and drug testing, to sponsors across the globe, typically into emerging markets. While it is clear that important ethical issues arise with this practice, unraveling moral responsibility and the allocation (...)
    Direct download (5 more)  
    Export citation  
    Bookmark   3 citations